Filing Details
- Accession Number:
- 0001209191-17-007630
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-03 16:35:20
- Reporting Period:
- 2017-02-01
- Filing Date:
- 2017-02-03
- Accepted Time:
- 2017-02-03 16:35:20
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1661567 | Michael Parini | 50 Northern Avenue Boston MA 02210 | Evp, Clo & Cao | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2017-02-01 | 3,450 | $85.98 | 10,350 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- Transaction made pursuant to Mr. Parini's company approved trading plan under Rule 10b5-1.